Vasculitis: Clinical Trials

6 trials for Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Unknown 6
Phase 23Unknown 3

Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
CD19-CAR-DNT cells - Systemic Lupus Erythematosus, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 1UnknownRenJi Hospital482023-10-302024-03-18
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome
Phase 1UnknownChongqing Precision Biotech Co., Ltd242023-08-312023-09-28
Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis
Nitroglycerin ointment, Clobetasol Topical - Phlebitis
Phase 1 / Phase 2UnknownKomar University of Science and Technology1102021-02-012020-12-28
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
Methylprednisolone Injection - Mucocutaneous Lymph Node Syndrome
Phase 1UnknownChang Gung Memorial Hospital102020-04-152020-08-11
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
ADRC injection, ADRC isolation, Liposuction - Critical Limb Ischemia, Arteriosclerosis Obliterans
Phase 1 / Phase 2UnknownCentral Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation92016-07-012016-08-12
Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
ResQ processed bone marrow sample, Ficoll conventional cell processing method - Critical Limb Ischemia, Peripheral Arterial Disease
Phase 1 / Phase 2UnknownXuanwu Hospital, Beijing502011-10-012011-10-12

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Chronic Limb-Threatening Ischemia (2)  ·  Lupus Erythematosus, Systemic (2)  ·  Peripheral Arterial Disease (2)  ·  Scleroderma, Systemic (2)  ·  Thromboangiitis Obliterans (2)  ·  Arteriosclerosis Obliterans (1)  ·  Coronary Aneurysm (1)  ·  Dermatomyositis (1)  ·  Diabetic Angiopathies (1)  ·  Mucocutaneous Lymph Node Syndrome (1)  ·  Myositis (1)  ·  Phlebitis (1)  ·  Sjogren's Syndrome (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Vascular Diseases (6)  ·  Peripheral Vascular Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Atherosclerosis (2)  ·  Autoimmune Diseases (2)  ·  Chronic Disease (2)  ·  Connective Tissue Diseases (2)  ·  Disease Attributes (2)  ·  Immune System Diseases (2)

Interventions

Clobetasol (1)  ·  Cyclophosphamide (1)  ·  Lipectomy (1)  ·  Methylprednisolone (1)  ·  fludarabine (1)

Sponsors

Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chongqing Precision Biotech Co., Ltd (1)  ·  Komar University of Science and Technology (1)  ·  RenJi Hospital (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

China (3)  ·  Russia (1)  ·  Taiwan (1)

Top investigators

Andrey A Kalinin, MD, PhD (1)  ·  Andrey A Pulin, MD, PhD (1)  ·  Evgeny R Lysenko, MD, PhD, Prof (1)  ·  Liyun Zhang, M.D (1)  ·  Yong-Quan Gu, Dr. (1)